Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric Cancer
NCT06426654
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
sintiliman plus LDRT
Sponsor
West China Hospital